Comparison between Asston Pharmaceuticals IPO and Shlokka Dyes IPO.
Asston Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Shlokka Dyes IPO is a SME Bookbuilding proposed to list at BSE SME.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | Interactive Financial Services Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | JSK Securities & Services Pvt.Ltd. | Aftertrade Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Asston Pharmaceuticals IPO is up to ₹26.17 Cr whereas the issue size of the Shlokka Dyes IPO is up to ₹54.84 Cr. The final issue price of Asston Pharmaceuticals IPO is ₹123.00 per share and of Shlokka Dyes IPO is ₹91.00 per share.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹115.00 per share | ₹88.00 per share |
| Issue Price (Upper) | ₹123.00 per share | ₹91.00 per share |
| Issue Price (Final) | ₹123.00 per share | ₹91.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1200 shares |
| Fresh Issue Size | 21,28,000 shares | 60,26,400 shares |
| Fresh Issue Size (Amount) | up to ₹26.17 Cr | up to ₹54.84 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,28,000 shares | 60,26,400 shares |
| Issue Size Total (Amount) | up to ₹26.17 Cr | up to ₹54.84 Cr |
Asston Pharmaceuticals IPO opens on Jul 09, 2025, while Shlokka Dyes IPO opens on Sep 30, 2025. The closing date of Asston Pharmaceuticals IPO and Shlokka Dyes IPO is Jul 11, 2025, and Oct 14, 2025, respectively.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| Anchor Bid Date | Jul 08, 2025 | |
| Issue Open | Jul 09, 2025 | Sep 30, 2025 |
| Issue Close | Jul 11, 2025 | Oct 14, 2025 |
| Basis Of Allotment (Tentative) | Jul 14, 2025 | Oct 15, 2025 |
| Initiation of Refunds (Tentative) | Jul 15, 2025 | Oct 16, 2025 |
| Credit of Share (Tentative) | Jul 15, 2025 | Oct 16, 2025 |
| Listing date (Tentative) | Jul 16, 2025 | Oct 17, 2025 |
| Anchor Lockin End date 1 | Aug 13, 2025 | |
| Anchor Lockin End date 2 | Oct 12, 2025 |
Asston Pharmaceuticals IPO P/E ratio is 17.83, as compared to Shlokka Dyes IPO P/E ratio of 13.69.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Asston Pharmaceuticals Ltd.'s revenue increased by 62% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Standalone)Shlokka Dyes Ltd.'s revenue increased by 68% and profit after tax (PAT) rose by 104% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 68.76 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 50.66 | 71.33 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.83 | 13.69 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹104.70 Cr. | ₹194.82 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.56% | 36.82% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 51.25% | 36.14% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.68 | 1.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.90 | ₹6.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 40.36% | 36.73% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Asston Pharmaceuticals IPO Retail Individual Investors (RII) are offered 7,46,000 shares while in Shlokka Dyes IPO retail investors are offered 7,46,000 shares. Qualified Institutional Buyers (QIB) are offered 4,25,000 shares in Asston Pharmaceuticals IPO and 6,03,600 shares in Shlokka Dyes IPO.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| Anchor Investor Reservation | 6,35,000 shares | 0 shares |
| Market Maker Reservation | 1,13,000 shares | 3,24,000 shares |
| QIB | 4,25,000 shares | 6,03,600 shares |
| NII | 3,22,000 shares | 16,26,000 shares |
| RII | 7,46,000 shares | 37,96,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 21,28,000 shares | 60,26,400 shares |
Asston Pharmaceuticals IPO subscribed 186.55x in total, whereas Shlokka Dyes IPO subscribed 1.12x.
| Asston Pharmaceuticals IPO | Shlokka Dyes IPO | |
|---|---|---|
| QIB (times) | 85.76x | 1.02x |
| NII (times) | 353.14x | 2.24x |
| Big NII (times) | 424.47x | 3.09x |
| Small NII (times) | 210.85x | 0.54x |
| RII (times) | 172.06x | 0.65x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 186.55x | 1.12x |
